Dr. Crowe received her PhD in Molecular Cellular, and Developmental Biology from Ohio State after obtaining her MS in Biology from Missouri State University. She currently is an assistant professor in the Department of Biology at Xavier University in Cincinnati. Her laboratory group focuses on utilizing in-vitro models to develop biomarkers for assessment of gene therapy in GNE myopathy, a disease of progressive muscle wasting. She took over in 2021 as the Associate Director of North Central Region for Sigma Xi, the scientific research honor society and last year received the Sigma Xi Linda H. Mantel Next Generation Women’s Leadership Award, recognizing outstanding service and leadership potential of an early career researcher/scholar. Dr. Crowe is also passionate about engaging in science outreach to the community with the goal of promoting public understanding of scientific research.
Kelly Crowe
